换一批
换一批摘要如何早期识别慢性肾脏病(CKD)、识别并处理影响其进展的危险因素、纠正并延缓终末期肾病(ESRD)的发生及恶化,是肾脏病界努力的三大策略.随着肿瘤个体化治疗的兴起,人们开始致力于寻找并应用生物学标记对CKD易感及其进展的危险因素进行个体化诊断,以期为CKD病患者的个体化干预及治疗奠定基础.
更多相关知识
abstractsThree strategies for nephrologists are to recognize the signs of early diagnosis of chronic kidney disease ( CKD),to identify and treat risk factors of progression of CKD and to cure or slow-down the progress of end-stage renal disease (ESRD). The idea of individual therapies obtaining optimal clinical results in tumor treatment urged people to find and apply biomarkers for personalized diagnosis of the risk factors of CKD susceptibility and progression,which provide a rationale for pursuing personalized medicine.(Chin J Lab Med,2012,35:784-789)
More相关知识
关键词
慢性病肾疾病肾功能衰竭,慢性尿毒症生物学标记Chronic diseaseKidney diseasesKidney failure,chronicUremiaBiological markers
分类号
R544.1
栏目名称
专家论坛
DOI
10.3760/cma.j.issn.1009-9158.2012.09.004
发布时间
2012-12-26
- 浏览383
- 被引1
- 下载92
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
